Villere ST Denis J & Co. LLC Buys 12,296 Shares of Teleflex Incorporated (NYSE:TFX)

Villere ST Denis J & Co. LLC lifted its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 9.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 149,276 shares of the medical technology company's stock after purchasing an additional 12,296 shares during the quarter. Teleflex accounts for about 2.4% of Villere ST Denis J & Co. LLC's holdings, making the stock its 21st largest position. Villere ST Denis J & Co. LLC owned about 0.32% of Teleflex worth $26,568,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Janus Henderson Group PLC raised its stake in shares of Teleflex by 2.8% during the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company's stock valued at $1,329,704,000 after purchasing an additional 147,147 shares during the period. State Street Corp raised its stake in shares of Teleflex by 1.0% during the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company's stock valued at $508,757,000 after purchasing an additional 21,291 shares during the period. Geode Capital Management LLC raised its stake in shares of Teleflex by 0.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company's stock valued at $278,676,000 after purchasing an additional 5,746 shares during the period. Massachusetts Financial Services Co. MA raised its stake in shares of Teleflex by 0.4% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company's stock valued at $105,749,000 after purchasing an additional 1,884 shares during the period. Finally, Point72 Asset Management L.P. raised its stake in shares of Teleflex by 31.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company's stock valued at $100,768,000 after purchasing an additional 96,958 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Teleflex Price Performance

Shares of TFX traded up $5.41 during midday trading on Wednesday, reaching $174.74. The stock had a trading volume of 591,250 shares, compared to its average volume of 518,686. The company's 50-day moving average is $177.41 and its 200 day moving average is $208.26. Teleflex Incorporated has a 12-month low of $165.62 and a 12-month high of $253.06. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $8.12 billion, a price-to-earnings ratio of 34.74, a price-to-earnings-growth ratio of 1.65 and a beta of 1.16.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on TFX shares. Truist Financial reduced their target price on Teleflex from $227.00 to $200.00 and set a "hold" rating for the company in a research report on Wednesday, December 18th. Mizuho reduced their target price on Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a research report on Friday, November 1st. Royal Bank of Canada reduced their target price on Teleflex from $275.00 to $245.00 and set an "outperform" rating for the company in a research report on Friday, November 1st. StockNews.com upgraded Teleflex from a "hold" rating to a "buy" rating in a research report on Thursday, November 28th. Finally, Needham & Company LLC restated a "hold" rating on shares of Teleflex in a research report on Monday, December 16th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Teleflex has a consensus rating of "Moderate Buy" and an average price target of $252.50.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.